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Abstract
Background: Hospital mortality in patients with severe acute pancreatitis (SAP) remains high.
Some of these patients develop increased intra-abdominal pressure (IAP) which may contribute to
organ dysfunction. The aims of this study were to evaluate the frequency of increased IAP in
patients with SAP and to assess the development of organ dysfunction and factors associated with
high IAP.
Methods: During 2001–2003 a total of 59 patients with severe acute pancreatitis were treated in
the intensive care unit (ICU) of Helsinki University Hospital. IAP was measured by the intravesical
route in 37 patients with SAP. Data from these patients were retrospectively reviewed.
Results: Maximal IAP, APACHE II score, maximal SOFA score, maximal creatinine, age and
maximal lactate were significantly higher in nonsurvivors. There was a significant correlation of the
maximal IAP with the maximal SOFA, APACHE II, maximal creatinine, maximal lactate, base deficit
and ICU length of stay. Patients were divided into quartiles according to the maximal IAP. Maximal
IAP was 7–14, 15–18, 19–24 and 25–33 mmHg and the hospital mortality rate 10%, 12.5%, 22.2%
and 50% in groups 1–4, respectively. A statistically significant difference was seen in the maximal
SOFA, ICU length of stay, maximal creatinine and lactate values. The mean ICU-free days in groups
1–4 were 45.7, 38.8, 32.0 and 27.5 days, respectively. The difference between groups 1 and 4 was
statistically significant.
Conclusion: In patients with SAP, increased IAP is associated with development of early organ
failure reflected in increased mortality and fewer ICU-free days. Frequent measurement of IAP
during intensive care is important in optimizing abdominal perfusion pressure and recognizing
patients potentially benefitting from decompressive laparotomy.
Background
In spite of advances in the treatment of severe acute pan-
creatitis, the hospital mortality rate remains high [1,2].
The major determinants of death are multiple organ fail-
ure (MOF), the extent of necrotic pancreatic parenchyma
and the presence of bacterial infection [3]. Recent clinical
experience has indicated that some patients dying of
"early MOF" might have suffered from untreated abdom-
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inal compartment syndrome (ACS). Massive fluid resusci-
tation in the early course of the disease combined with the
severe inflammatory process in the retroperitoneum
could contribute to visceral oedema leading to increased
intra-abdominal pressure (IAP). This acute increase of IAP
may in the severe cases lead to early organ dysfunction
and ACS [4].
In healthy individuals, IAP ranges from 0 to 5 mmHg and
varies with the respiratory cycle [5,6]. Because the organs
and other contents in abdomen are relatively noncom-
pressible, any increase in the volume of the retroperito-
neal or abdominal contents increases IAP. New consensus
definitions for IAH (intra-abdominal hypertension) and
ACS were set by the World Society on the Abdominal
Compartment Syndrome (WSACS) [7]. IAH is a sustained
increase in IAP above 12 mmHg. ACS is a sustained
increase in IAP above 20 mmHg with new onset organ
failure with or without a low APP. However, even values
of lower than 15 mmHg may cause organ dysfunction
[8,9].
The prevalence of IAH in critically ill patients depends on
the threshold used. Most commonly, the maximal IAP
value instead of median or mean IAP has been used. In
patients with severe acute pancreatitis, IAP >25 mmHg
was detected in 30% of patients [10]. In a recent study,
IAP > 15 mmHg was found in 78% of the patients with
severe acute pancreatitis [11]. In a mixed population of
ICU patients, prevalence of IAH (cut-off 12 mmHg) was
59%, 8.2% of these patients were classified as having ACS
[12]. In another study with mixed ICU population, 32%
of the patients had IAH (cut-off 12 mmHg) and 4.2% had
ACS on admission [13]. In abdominal surgical patients,
incidence of IAH (cut-off 20 mmHg) was 33 to 39%
[14,15] and incidence of ACS (cut-off 20–25 mmHg) 2–
36% [15-18].
This was a study on primary IAH and ACS according to the
WSACS definitions. The aims of this study were to evalu-
ate the degree of increased intra-abdominal pressure (IAP)
in a group of patients with severe acute pancreatitis and to
assess the development and progression of organ dysfunc-
tion and other factors associated with high IAP.
Methods
Patients
ICU computerized database was used to identify all
patients with severe acute pancreatitis treated in the ICU
of Helsinki University Hospital during 2001–2003. Severe
acute pancreatitis was diagnosed, if the patients presented
with abdominal pain, increased serum amylases and at
least one organ dysfunction. The diagnosis was confirmed
by abdominal CT in all but one patient. IAP was measured
by the intravesical route in 37 of these 59 patients. IAP
was measured if IAH was clinically suspected due to severe
distension of the abdomen combined with a new or a
worsening organ failure.
Definitions
Acute Physiology And Chronic Health Evaluation
(APACHE) II score [19] and Balthazar classifications [20]
were used to assess the severity of pancreatitis. Balthazar
classification: Grade A – normal CT, Grade B – focal or dif-
fuse enlargement of the pancreas, Grade C – pancreatic
gland abnormalities and peripancreatic inflammation,
Grade D – fluid collection in a single location, Grade E –
two or more collections and/or gas bubbles in or adjacent
to pancreas. Sequential Organ Failure Assessment (SOFA)
score [21] was calculated daily to assess the extent of
organ dysfunction, using the worst value of each day.
Based on the highest measured IAP value, the patients
were divided into quartiles.
Data collection
Patient data were retrospectively retrieved from the com-
puterized patient database and the patient records. Age,
gender, height, weight, body mass index (BMI), length of
ICU stay, ICU-free days (out of 60 days), length of hospi-
tal stay, hospital mortality, medical history, etiology of
pancreatitis and type of admission (primary or referral)
were recorded. Parameters collected (days 1–14 in ICU)
were IAP, lactate, C-reactive protein (CRP) at admission,
creatinine, base deficit, need of renal replacement therapy,
amount of fluids given, fluid balance, amount of perito-
neal fluid (small, moderate or large; evaluated with CT),
daily SOFA score, APACHE II score at admission and
laparotomies during the ICU stay.
Intra-abdominal pressure
Intra-abdominal pressure was measured through a Foley
bladder catheter [22,23]. Intravenous infusion set was
connected to normal saline, three-way stopcock and a dis-
posable pressure transducer. The urometer was cut near
the Foley catheter and the transducer was connected to the
urometer by a three-way stopcock. The infusion set was
flushed with saline and the pressure transducer was
zeroed at the level of symphysis pubis. With the patient in
supine position, 50 ml of saline were injected into the
bladder and IAP was measured during end expiration.
Nowadays minimal instillation volumes (<25 ml) are
used for IAP measurement [7,24,25].
Statistical analysis
Statistical analyses were performed using the SPSS soft-
ware (Statistical package for the social sciences version
12.01, Chicago, IL, USA). Correlations between parame-
ters were tested with Spearman's non-parametric correla-
tion. Patients were divided into quartiles according to the
maximal IAP measured. Kruskall-Wallis test was used toWorld Journal of Emergency Surgery 2007, 2:2 http://www.wjes.org/content/2/1/2
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test statistical significance between multiple groups in
continuous variables. Fisher exact test was used in dichot-
omous variables. Mann-Whitney test was used to test sig-
nificance between two groups. Results are expressed as
medians with interquartile (IQ) ranges. ICU-free days out
of 60 are expressed as means. A p-value less than 0.05 was
considered statistically significant.
Results
The overall hospital mortality rate was 24% (9 out of 37)
in our study group. According to the WSACS definition,
IAH was found in 84% (31 out of 37) of patients. 17/37
(46%) patients had recurrent IAH. 18/37 (49%) patients
had ACS and 7/37 (19%) had recurrent ACS. Table 1 sum-
marizes the demographic and clinical data among survi-
vors and nonsurvivors. The median age of the patients was
46 years (range 21–69 years), the most common etiologi-
cal factor in this series was alcohol abuse (84%). Five
patients underwent abdominal operations during the two
first weeks in the ICU, additional four patients later on.
The indication for two of the laparotomies during the
study period was ACS. In patient 1 IAP decreased postop-
eratively from 33 mmHg to 16–22 mmHg. The urine out-
put increased from less than 1 ml/kg/h to more than 2 ml/
kg/h, plasma lactate normalized, and ventilatory function
improved. In patient 2 IAP decreased postoperatively
from 25 mmHg to 13 mmHg. The urine output increased
from less than 0.5 ml/kg/h to 1.5 ml/kg/h and the venti-
latory function improved. These effects on IAP were sus-
tained in both of these patients over several days. Other
reasons for laparotomy included intra-abdominal hemor-
rhage, suspected bowel perforation, and verified or sus-
pected infection of the peripancreatic necrosis. 43% (16 of
37) of the patients required renal replacement therapy.
For those 22 patients in whom the IAP was not measured
the mortality rate was 18%.
The maximal IAP, APACHE II score at admission, maxi-
mal SOFA score, age, maximal plasma lactate, maximal
creatinine and base deficit were significantly higher in the
nonsurvivors (Table 2). There was a significant correlation
of the maximal IAP with the maximal SOFA score (coeffi-
cient 0.49, p = 0.001) (Fig. 1), APACHE II score (0.50, p =
0.001), maximal lactate value (0.46, p = 0.002), base def-
icit (0.43, p = 0.008), maximal creatinine (0.56, p <
0.001) and duration of intensive care (0.48, p = 0.001).
Maximal IAP did not correlate with the length of hospital
stay or body-mass index (Spearman's non-parametric cor-
relation).
Figure 2 illustrates that nonsurvivors had higher maximal
IAP, total SOFA, SOFA cardiovascular and renal scores on
ICU-days 1–7 than survivors, whereas there was no signif-
icant difference in SOFA respiratory, coagulation, hepatic
or neurological score (data not shown). Patients were
divided into quartiles (8–10 patients in each group)
according to the maximal IAP measured during days 1–14
in the ICU with maximum IAP values of 7–14, 16–18, 19–
24 and 25–33 mmHg in groups 1 – 4, respectively. The
hospital mortality rates in groups 1–4 were 10%, 12.5%,
22.2% and 50%, respectively. A statistically significant dif-
ference (Kruskall-Wallis test) between groups was seen in
the maximal SOFA score (p = 0.01), maximal creatinine
values (p = 0.01), duration of intensive care (p = 0.038)
and maximal lactate values (p = 0.039). The difference in
mortality rates between groups 1 and 4 was not statisti-
cally significant (p = 0.14; Fisher exact test). The mean
ICU-free days in groups 1–4 were 45.7, 38.8, 32.0 and
27.5 days, respectively (p = 0.045, Kruskall-Wallis test).
The difference in ICU-free days between groups 1 and 4
was statistically significant (p = 0.023, Mann-Whitney
test). ROC (receiver operating characteristics) curves for
IAP max day 1–7, SOFA day 1 and APACHE II are shown
in Figure 3.
Discussion
We found in this study, that high IAP in critically ill
patients with acute pancreatitis correlates with the degree
of organ dysfunction and length of intensive care.
Table 1: Demographic and clinical data of patients treated for 
severe acute pancreatitis.
All (%)
37 (100)
Male 33 (89)
Age (years) median, range 46 (21–69)
BMI (kg/m2) median, range 28 (21–42)
Pre-existing diseases
Hypertension 10 (27)
Diabetes 2 (5)
Cardiovascular 3 (8)
Hyperlipidemy 2 (5)
Chronic pancreatitis 2 (5)
Respiratory 2 (5)
Renal 2 (5)
Psychiatric 4 (11)
Etiology
Alcohol 31 (84)
Biliary 6 (16)
Amount of peritoneal fluid in CT
small 13 (35)
moderate 19 (51)
large 4 (11)
Balthazar classification
A, B 0 (0)
C1  ( 3 )
D1  ( 3 )
E3 4  ( 9 2 )
no CT 1 (3)
Primary admission 4 (11)
CT, computed tomography; BMI, body-mass indexWorld Journal of Emergency Surgery 2007, 2:2 http://www.wjes.org/content/2/1/2
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Increased IAP has deleterious effects on several organ sys-
tems. Cardiovascular effects include decrease in cardiac
output, ventricular end-diastolic volume, preload and
venous return, and increase in afterload and intrathoracic
pressure [14,26]. Respiratory failure is caused by the ele-
vation of the diaphragm leading to a decline in lung and
chest wall compliance, decrease in functional residual
capacity, total lung capacity and residual volume. Ventila-
tion-perfusion mismatch leads to hypoxia, hypercapnia
and need of mechanical ventilation. Renal dysfunction is
probably caused by a decrease in renal perfusion pressure,
the filtration gradient and renal blood flow. Splanchnic
perfusion may diminish due to a decrease in cardiac out-
put or a direct mechanical compression of the splanchnic
bed. Increased concentrations of vasopressin may also
play a role in the development of splanchnic ischemia
[27-31]. Several scoring systems such as APACHE II [19]
and SAPS [32] have been developed to predict outcome of
critically ill patients. However, IAP is not included in any
of these.
In earlier studies, an increase in IAP has been shown to be
associated with increased mortality in surgical and trauma
patients [17,18,29,30]. In trauma patients and liver recip-
ients, acute ACS was associated with multiorgan failure
and increased mortality [33-35]. In a recent multicenter
study, the prevalence of IAH in critically ill patients was
more than 50% [12]. In another study in a mixed ICU
population, IAH during intensive care was an independ-
ent outcome predictor [13].
In our study, the hospital mortality rate showed an
increasing trend from 10% to 50% with the maximal IAP
increasing from 7–14 to 25–33 mmHg, respectively. The
maximal IAP correlated with the highest SOFA score,
APACHE II-score on admission, maximal lactate and cre-
atinine values, base deficit and the duration of intensive
care. For quartiles divided by maximal IAP, the mean ICU-
free days significantly decreased with increasing maximal
IAP values. In a recent study, where IAP was measured in
patients with SAP only when IAH was clinically suspected,
the incidence of IAH was 78%. This is in agreement with
our study where the incidence of IAH was 84%. In the cur-
rent study the IAP showed an increasing trend during the
first week in the ICU in non-survivors, whereas it
decreased in survivors during the same time period. In
contrast, SOFA score remained relatively unchanged in
non-survivors. This may indicate that IAP could be a sen-
sitive indicator of poor prognosis in patients with SAP.
However, a larger study to confirm this finding is needed.
As a limitation to this study IAP was not measured in all
patients with SAP in our ICU during the study period.
Also, the patient number was not large enough to com-
pare the predictive value of different factors on patient
outcome. However, the adverse effects of high IAP on dif-
Correlation of maximal intra-abdominal pressure (IAP) with  maximal Sequential Organ Failure Assessment (SOFA) score  in survivors and nonsurvivors with severe acute pancreatitis Figure 1
Correlation of maximal intra-abdominal pressure (IAP) with 
maximal Sequential Organ Failure Assessment (SOFA) score 
in survivors and nonsurvivors with severe acute pancreatitis.
Table 2: ICU data from survivors and nonsurvivors of severe acute pancreatitis.
Nonsurvivors Survivors
Median (IQ range) Median (IQ range) p value
IAP max (mmHg) 25 (19.5–27.5) 18 (13.3–22.8) 0.043
SOFA max 14 (12.5–16) 10.5 (7.3–11.8) 0.003
ICU stay (days) 27 (7.0–54.0) 15.5 (7.3–20.8) 0.257
Hospital stay (days) 28 (9.5–107.5) 26 (20.0–37.5) 0.986
CRP at admission (mg/l) 293 (212–385) 316 (246–378) 0.671
APACHE II 19 (17.0–22.5) 13 (10.0–17.0) 0.001
Lactate max (mmol/l) 2.7 (2.1–7.1) 1.5 (1.3–2.1) 0.006
BE min (mmol/l) -10.5 (-13.2-(-8.0)) -1.3 (-6.6-(-1.3)) <0.001
Creatinine max (mmol/l) 338 (181.5–547) 140.5 (67.5–280.3) 0.020
IAP, Intra-abdominal pressure; SOFA, sequential organ failure assessment; BMI, body mass index; ICU, intensive care unit; CRP, C-reactive protein; 
APACHE II, Acure Physiology And Chronic Health Evaluation; BE, base excessWorld Journal of Emergency Surgery 2007, 2:2 http://www.wjes.org/content/2/1/2
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ferent organ systems are fairly well documented and IAH
may be a contributing factor to worsening organ function
(SOFA score) in patients with SAP.
For patients with severe acute pancreatitis IAH could be
especially deleterious because increased IAP in animal
studies has been associated with bacterial translocation
[36,37]. General splanchnic hypoperfusion and decreased
blood flow to pancreas together with bacterial transloca-
tion may predispose the patient to infected necrosis and
poor outcome [31]. However, the role and the treatment
of IAH in severe acute pancreatitis still remains to be elu-
cidated. Recently published international recommenda-
tions on the management of severe acute pancreatitis do
not specifically address the management of IAH or ACS
[38].
Once ACS is recognized, prompt treatment with decom-
pressive laparotomy seems to be the best option although
the exact indications, threshold IAP values and the most
appropriate technique need further research. It is even
more crucial in view of the considerable morbidity associ-
ated with the procedure itself, especially if the fascial clo-
sure is impossible leading to an open abdomen with
significant long-term morbidity and need for reconstruc-
tive surgery of the abdominal wall later on. As shown in
selected trauma and other surgical patients, however, the
risk of organ dysfunction can be decreased with timely
decompressive laparotomy in patients not responding to
nonoperative management of severe IAH [18,39,40]. The
same effect can be expected in patient with severe acute
pancreatitis.
Conclusion
In patients with severe acute pancreatitis, increased IAP is
associated with development of early organ failure and
fewer ICU-free days. Frequent measurement of IAP during
intensive care in patients with severe acute pancreatitis
could be important in optimizing abdominal perfusion
pressure and recognizing patients potentially benefiting
from early decompressive laparotomy.
ROC curves for IAP max day 1–7, APACHE II and day 1  SOFA points Figure 3
ROC curves for IAP max day 1–7, APACHE II and day 1 
SOFA points. AUC: area under curve.
Maximal intra-abdominal pressure (IAP) values, total Sequen- tial Organ Failure Assessment (SOFA) score, cardiovascular  and renal SOFA scores during ICU-days 1–7 in the survivors  and nonsurvivors of severe acute pancreatitis Figure 2
Maximal intra-abdominal pressure (IAP) values, total Sequen-
tial Organ Failure Assessment (SOFA) score, cardiovascular 
and renal SOFA scores during ICU-days 1–7 in the survivors 
and nonsurvivors of severe acute pancreatitis. Dots/lines 
represent medians.World Journal of Emergency Surgery 2007, 2:2 http://www.wjes.org/content/2/1/2
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